Trial Profile

Phase 1 Trial of Celyvir in Children and Adults With Metastatic and Refractory Solid Tumors

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 21 Jun 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Oncolytic virus based cell therapy Hospital Infantil Universitario Nino Jesus/Orgenesis (Primary)
Indications Astrocytoma; Carcinoma; Colorectal cancer; Ewing's sarcoma; Lung cancer; Medulloblastoma; Neuroblastoma; Osteosarcoma; Rhabdomyosarcoma; Soft tissue sarcoma; Solid tumours; Thymoma; Thyroid cancer
Focus Adverse reactions; First in man; Therapeutic Use

Most Recent Events

31 May 2020 Results presented at the 56th Annual Meeting of the American Society of Clinical Oncology
30 Apr 2013 Planned number of patients changed from 10 to 20 as reported by ClinicalTrials.gov.
30 Apr 2013 Planned End Date changed from 7 Feb 2012 to 1 Mar 2015 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com